This program is provided by Oakstone Publishing, LLC.
This program is produced by Oakstone Publishing, LLC.
Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative faculty of Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular Disorders will help you to better:
Diagnose and manage common neuromuscular problems, including motor neuron disease, peripheral neuropathies, neuromuscular junction disorders, and myopathies
Understand when to order specific laboratory and genetic tests, muscle and nerve biopsies, and recognize the prevalence of ordering unnecessary tests for patients with acquired and hereditary peripheral neuropathy
Diagnose late-onset Pompe disease, and manage the condition with the only medication approved by the FDA
Together, the faculty of this CME program will help practicing neurologists and physiatrists improve their use of EMG, nerve conduction studies, and other highly specialized studies.
This activity is primarily intended for practicing neurologists and psychiatrists as well as residents and fellows in Neurology and Physical Medicine and Rehabilitation.
Upon completion of this activity, the participant will be able to:
Perform a thorough history and neurological exam in order to recognize common and uncommon neuromuscular diseases
Apply current electrodiagnostic and neuromuscular medical literature to the evaluation and management of patients with neuromuscular disorders
Analyze those situations regarding lab tests, electrodiagnostic studies, imaging studies, and muscle and nerve biopsies as to whether they could be necessary or unnecessary for diagnosis
Assess relevant treatment options
Develop improved competence in providing optimal care to the patient with a neuromuscular disorder
Predict and manage patient expectations regarding treatment options, outcomes, and prognosis
Topics and Speakers
Click here for a complete list of course topics and speakers.
Anthony A. Amato, MD Vice-Chairman, Department of Neurology Chief, Neuromuscular Division Brigham and Women’s Hospital Professor of Neurology Harvard Medical School Boston, MA
William S. David, MD, PhD Director of EMG Laboratory and Neuromuscular Diagnostic Center Massachusetts General Hospital Associate Professor of Neurology Harvard Medical School Boston, MA
Anthony A. Amato, MD Vice-Chairman, Department of Neurology, Chief Neuromuscular Division, Brigham and Women’s Hospital Professor of Neurology Harvard Medical School Boston, MA Reports no commercial interest
David A. Chad, MD Staff Neurologist, Massachusetts General Hospital Associate Professor of Neurology Harvard Medical School, Boston MA Reports no commercial interest
Thomas I. Cochrane, MD, MBA Associate Neurologist, Brigham and Women’s Hospital Assistant Professor of Neurology, Harvard Medical School, Boston, MA Reports no commercial interest
William S. David, MD, PhD Director of EMG Laboratory and Neuromuscular Diagnostic Center Massachusetts General Hospital Associate Professor of Neurology Harvard Medical School Boston, MA Reports no commercial interest
Vera Fridman, MD Instructor in Neurology Harvard Medical School Assistant in Neurology Massachusetts General Hospital Boston, MA Reports no commercial interest
Amanda C. Guidon, MD Instructor in Neurology, Harvard Medical School Massachusetts General Hospital, Boston, MA Reports no commercial interest
Mohammed Kian Salajegheh Assistant Professor of Neurology Brigham and Women’s Hospital Harvard Medical School, Boston, MA Reports no commercial interest
Nutan Sharma, MD, PhD Associate Professor of Neurology Harvard Medical School Associate in Neurology Massachusetts General Hospital Associate Neurologist Brigham and Women’s Hospital Boston, MA Reports no commercial interest
Katherine B. Sims, MD Director Neurogenetics and Mitochondrial Disorders Clinic Massachusetts General Hospital Professor of Neurology Harvard Medical School Boston, MA Reports no commercial interest
James D. Berry, MD, MPH Assistant Professor of Neurology Harvard Medical School Assistant in Neurology, Massachusetts General Hospital Boston, MA Research-Grants: ALS Association; Muscular Dystrophy Association, ALS Therapy Alliance, ALS Therapy Development Institute Advisory Role: Neuraltus Pharmaceuticals, Inc Independent Contractor: Cytokinetics, GlaxoSmithKline, Genervon Biopharmaceuticals Material Support: Novartis
Basil T. Darras, MD Professor of Neurology Harvard Medical School Associate Neurologist-in-Chief Joseph J. Volpe Chair in Neurology Chief, Division of Clinical Neurology Director, Neuromuscular Program Boston Children’s Hospital, Boston, MA Research-Grants: PTC Therapeutics, Isis Pharmaceuticals, NIH/NINDS 1U10NS077269, NIH/NIAMS 1R01AR060850, SMA Foundation, Muscular Dystrophy Association, Slaney Family Fund for SMA Advisory Role: Isis Pharmaceuticals, Quest Diagnostics, Guidepoint Global Consultation, Easton Associates Consultation, Clearview Healthcare Partners, Gershon Lehrman Group
Erik R. Ensrud, MD Director, Neuromuscular Center and EMG Lab Boston VA Medical Center; Director Neuromuscular Rehabilitation Clinic Brigham and Women’s Hospital Boston, MA Advisory Role: Skulpt, Inc., FDA Honoraria: Osler Medical
Steven A. Greenberg, MD Associate Professor Department of Neurology Brigham and Women’s Hospital Boston Children’s Hospital Informatics Program Harvard-MIT Division of Health Sciences and Technology Harvard Medical School, Boston, MA S.A.G. is an inventor on intellectual property owned and managed by Brigham and Women’s Hospital
Steve S. Han, MD, PhD Assistant in Neurology Department of Neurology Massachusetts General Hospital Boston, MA Biogen-Idec, salary as employee
Sanjeev D. Nandedkar, PhD Senior Consultant, CareFusion Middleton, WI Natus Medical Inc Employed by Natus Medical who makes EMG systems No conflict
Sabrina Paganoni, MD, PhD Harvard Medical School; Department of Physical Medicine and Rehabilitation Spaulding Rehabilitation Hospital Massachusetts General Hospital Boston, MA Research-Grants: NIH Career Development Award
Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, content reviewers, and editorial staff disclose no relevant commercial interests.
AMA PRA Category 1 Credit(s)TM
Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Oakstone Publishing, LLC designates this enduring material for a maximum of 31.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The opinions and recommendations expressed by the faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Oakstone Publishing, LLC name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
METHOD OF PARTICIPATION: Once logged into the website, review the audio/videos, complete the comprehensive activity evaluation and score 70% or greater on the required post-test to assess the knowledge gained from reviewing the program. Once the activity and evaluation are complete and a satisfactory score is earned on the post test, you can print your CME certificate located under the certificate tab.
If you have any questions relating to the accreditation of this activity, please contact firstname.lastname@example.org.
Due to the nature of Oakstone’s product, its audio/video format and educational content, no refunds are permitted. You may return the product within 15 days of receipt and receive a credit reflective of the original price you paid for the item. This credit may be applied as payment to any product(s) produced by Oakstone Publishing, LLC. We guarantee your program against defects in materials. Simply return any defective materials, and we will replace them. To make a return, call 800-633-4743 for a Return Authorization Code. Complete the packing ticket and return with the program to 2700 Corporate Drive, Suite 100, Birmingham, AL 35242. We recommend shipping through UPS or FedEx. Return shipping fees are the responsibility of the purchaser.
ONLINE STREAMING Windows XP, Vista, 7 or 8 on Pc and Macintosh OS X or above on Mac computers with most current Flash player/Quicktime software and latest version of web browsers (Internet Explorer 7 or higher, Firefox 2.0 or higher, Safari 5 or higher and Chrome) for each.